George Arida is a Managing Director with Venture Investors LLC, with a focus on early- and growth-stage biotechnology and medical device opportunities.

George currently serves as the Board Chair for Chromatin, Inc. and Juventas Therapeutics, and served as Board Chair of Zystor Therapeutics (acquired by BioMarin Pharmaceutical Inc. – NASDAQ:BMRN), Nerites Corporation (acquired by Kensey Nash, now DSM), and Celleration, Inc. (acquired by Alliqua BioMedical – NASDAQ:ALQA), and also currently serves as member of the Board of Directors at NanoBio Corporation.  He is also a founding Director of the Mid-America Healthcare Investors Network, an association of over forty regional venture capital firms active in early stage healthcare investing.

George previously served as the CFO for a financial consulting and brokerage firm in Chicago, IL.  Prior to this, he spent five years at U.S. Filter Corporation in management and technical marketing positions, four years with Betz Laboratories in technical sales and field service management, and two years at Alar Engineering as a Process Engineer.  George has a Bachelor of Science degree in Chemical Engineering from the University of Illinois at Urbana-Champaign and a Master of Business Administration degree with high honors from the University of Chicago.